Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia

E. Berman, G. Heller, J. A. Santorsa, S. McKenzie, T. Gee, S. Kempin, S. Gulati, M. Andreeff, J. Kolitz, J. Gabrilove, L. Reich, K. Mayer, D. Keefe, K. Trainor, A. Schluger, D. Penenberg, V. Raymond, R. O'Reilly, S. Jhanwar

Research output: Contribution to journalArticlepeer-review

363 Scopus citations

Fingerprint

Dive into the research topics of 'Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences